Nitric oxide synthase gene transfer restores activity of circulating angiogenic cells from patients with coronary artery disease

Molecular Therapy

Volumn 19, Issue 7, 2011, Pages 1323-1330

  Ward, Michael R ^a,b   Thompson, Kathleen A ^a   Isaac, Kathryn ^a   Vecchiarelli, Jonathan ^a   Zhang, Qiuwang ^a   Stewart, Duncan J ^c   Kutryk, Michael J B ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LENTIVIRUS VECTOR; MATRIGEL; NITRIC OXIDE;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CELL ACTIVITY; CELL MIGRATION; CELL REGENERATION; CHEMOTAXIS; CIRCULATING ANGIOGENIC CELL; COCULTURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELL; EX VIVO GENE TRANSFER; FEMALE; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HIGH RISK PATIENT; HINDLIMB; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; LIMB PERFUSION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; RISK FACTOR; STEM CELL TRANSPLANTATION; UMBILICAL VEIN ENDOTHELIAL CELL; VIRAL GENE DELIVERY SYSTEM; VOLUNTEER;

EID: 79959947559     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.52     Document Type: Article

References (38)

1. Asahara, T, Murohara, T, Sullivan, A, Silver, M, van der Zee, R, Li, T et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967. (Pubitemid 27087709)
2. Ward, MR, Stewart, DJ and Kutryk, MJ (2007). Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv 70: 983-998.
3. Walter, DH, Haendeler, J, Reinhold, J, Rochwalsky, U, Seeger, F, Honold, J et al. (2005). Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97: 1142-1151.
4. Asosingh, K, Aldred, MA, Vasanji, A, Drazba, J, Sharp, J, Farver, C et al. (2008). Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am J Pathol 172: 615-627. (Pubitemid 351354535)
5. Döbert, N, Britten, M, Assmus, B, Berner, U, Menzel, C, Lehmann, R et al. (2004). Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging 31: 1146-1151. (Pubitemid 39050182)
6. Hur, J, Yoon, CH, Kim, HS, Choi, JH, Kang, HJ, Hwang, KK et al. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293. (Pubitemid 38197580)
7. Kawamoto, A, Tkebuchava, T, Yamaguchi, J, Nishimura, H, Yoon, YS, Milliken, C et al. (2003). Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107: 461-468. (Pubitemid 36158050)
8. Fernández-Avilés, F, San Román, JA, García-Frade, J, Fernández, ME, Peñarrubia, MJ, de la Fuente, L et al. (2004). Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95: 742-748. (Pubitemid 39331935)
9. Schächinger, V, Erbs, S, Elsässer, A, Haberbosch, W, Hambrecht, R, Hölschermann, H et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221. (Pubitemid 44427445)
10. Li, ZQ, Zhang, M, Jing, YZ, Zhang, WW, Liu, Y, Cui, LJ et al. (2007). The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). Int J Cardiol 115: 52-56.
11. Abdel-Latif, A, Bolli, R, Tleyjeh, IM, Montori, VM, Perin, EC, Hornung, CA et al. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and metaanalysis. Arch Intern Med 167: 989-997. (Pubitemid 46835786)
12. Jiang, M, He, B, Zhang, Q, Ge, H, Zang, MH, Han, ZH et al. (2010). Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert Opin Biol Ther 10: 667-680.
13. Vasa, M, Fichtlscherer, S, Aicher, A, Adler, K, Urbich, C, Martin, H et al. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7.
14. Heiss, C, Keymel, S, Niesler, U, Ziemann, J, Kelm, M and Kalka, C (2005). Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45: 1441-1448. (Pubitemid 40615616)
15. Loomans, CJ, de Koning, EJ, Staal, FJ, Rookmaaker, MB, Verseyden, C, de Boer, HC et al. (2004). Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199. (Pubitemid 38044715)
16. Michaud, SE, Dussault, S, Haddad, P, Groleau, J and Rivard, A (2006). Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 187: 423-432. (Pubitemid 43963027)
17. Tepper, OM, Galiano, RD, Capla, JM, Kalka, C, Gagne, PJ, Jacobowitz, GR et al. (2002). Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786. (Pubitemid 35396976)
18. Yue, WS, Wang, M, Yan, GH, Yiu, KH, Yin, L, Lee, SW et al. (2010). Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease. Am J Cardiol 106: 1248-1254.
19. Aicher, A, Heeschen, C, Mildner-Rihm, C, Urbich, C, Ihling, C, Technau-Ihling, K et al. (2003). Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376. (Pubitemid 37466185)
20. Thum, T, Fraccarollo, D, Schultheiss, M, Froese, S, Galuppo, P, Widder, JD et al. (2007). Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56: 666-674. (Pubitemid 46348461)
21. Gulati, R, Jevremovic, D, Peterson, TE, Chatterjee, S, Shah, V, Vile, RG et al. (2003). Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93: 1023-1025. (Pubitemid 37485031)
22. Heeschen, C, Lehmann, R, Honold, J, Assmus, B, Aicher, A, Walter, DH et al. (2004). Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622. (Pubitemid 38451717)
23. Dimmeler, S and Zeiher, AM (1999). Nitric oxide-an endothelial cell survival factor. Cell Death Differ 6: 964-968. (Pubitemid 29520797)
24. Ziche, M, Morbidelli, L, Choudhuri, R, Zhang, HT, Donnini, S, Granger, HJ et al. (1997). Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634. (Pubitemid 27259809)
25. Namba, T, Koike, H, Murakami, K, Aoki, M, Makino, H, Hashiya, N et al. (2003). Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 108: 2250-2257. (Pubitemid 37363043)
26. Józkowicz, A, Dulak, J, Nigisch, A, Funovics, P, Weigel, G, Polterauer, P et al. (2004). Involvement of nitric oxide in angiogenic activities of vascular endothelial growth factor isoforms. Growth Factors 22: 19-28. (Pubitemid 38660582)
27. Yu, J, deMuinck, ED, Zhuang, Z, Drinane, M, Kauser, K, Rubanyi, GM et al. (2005). Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA 102: 10999-11004. (Pubitemid 41105982)
28. Guthrie, SM, Curtis, LM, Mames, RN, Simon, GG, Grant, MB and Scott, EW (2005). The nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells. Blood 105: 1916-1922. (Pubitemid 40731772)
29. Sasaki, K, Heeschen, C, Aicher, A, Ziebart, T, Honold, J, Urbich, C et al. (2006). Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA 103: 14537-14541. (Pubitemid 44484785)
30. Thum, T, Hoeber, S, Froese, S, Klink, I, Stichtenoth, DO, Galuppo, P et al. (2007). Age-dependent impairment of endothelial progenitor cells is corrected by growthhormone-mediated increase of insulin-like growth-factor-1. Circ Res 100: 434-443.
31. Wenzel, P, Daiber, A, Oelze, M, Brandt, M, Closs, E, Xu, J et al. (2008). Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 198: 65-76.
32. Boon, RA, Urbich, C, Fischer, A, Fontijn, RD, Seeger, FH, Koyanagi, M et al. (2011). Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells. Eur Heart J 32: 371-377.
33. Zhang, Y, Wittner, M, Bouamar, H, Jarrier, P, Vainchenker, W and Louache, F (2007). Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+ cells. Stem Cells 25: 211-219. (Pubitemid 46070113)
34. Segal, MS, Shah, R, Afzal, A, Perrault, CM, Chang, K, Schuler, A et al. (2006). Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55: 102-109. (Pubitemid 43343304)
35. Li Calzi, S, Purich, DL, Chang, KH, Afzal, A, Nakagawa, T, Busik, JV et al. (2008). Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes. Diabetes 57: 2488-2494.
36. DiFabio, JM, Thomas, GR, Zucco, L, Kuliszewski, MA, Bennett, BM, Kutryk, MJ et al. (2006). Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. J Pharmacol Exp Ther 318: 117-123.
37. Liu, JW, Pernod, G, Dunoyer-Geindre, S, Fish, RJ, Yang, H, Bounameaux, H et al. (2006). Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells 24: 199-208.
38. Leong-Poi, H, Kuliszewski, MA, Lekas, M, Sibbald, M, Teichert- Kuliszewska, K, Klibanov, AL et al. (2007). Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res 101: 295-303. (Pubitemid 47344079)